HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Winkel, C. A. Search for Related Content PubMed PubMed Citation Articles by Winkel, C. A.

Evaluation and Management of Women With Endometriosis

From the Department of Obstetrics and Gynecology, Georgetown University, Washington, DC.

Address reprint requests to: Craig A. Winkel, MD, MBA, Department of Obstetrics and Gynecology, Georgetown University, 3800 Reservoir Road NW, #3PHC, Washington, DC 20007; E-mail: winkelc{at}gunet.georgetown.edu.

Endometriosis is a condition that often leads to a variety of symptoms that range from pain complaints to infertility. Endometriosis is also found in women who are asymptomatic. The diagnosis of endometriosis can be made clinically with reliability similar to that of one made surgically. Medical treatment options are effective, as are surgical treatment options. Complications associated with surgery, however, push the balance in favor of medical therapy whenever possible. Based on the body of evidence available at present, women with endometriosis-related complaints should be treated with a first-line medical therapy. If that fails, a second-line medical therapy is warranted under most conditions. Laparoscopic surgery should be reserved for patients in whom second-line medical therapy has failed or is contraindicated by desire to conceive immediately or as soon as possible.

This article has been cited by other articles:

				K. K. Algoe, H. Chen, A. R. Schned, and J. L. Whiteside Intraperitoneal India Ink Deposits Appearing as Endometriosis in a Patient With Chronic Pelvic Pain Obstet. Gynecol., August 1, 2008; 112(2): 448 - 450. [Abstract] [Full Text] [PDF]

				H. C. Bohler, C. Gercel-Taylor, B. A. Lessey, and D. D. Taylor Endometriosis Markers: Immunologic Alterations as Diagnostic Indicators for Endometriosis Reproductive Sciences, September 1, 2007; 14(6): 595 - 604. [Abstract] [PDF]

				S. Simoens, L. Hummelshoj, and T. D'Hooghe Endometriosis: cost estimates and methodological perspective Hum. Reprod. Update, July 1, 2007; 13(4): 395 - 404. [Abstract] [Full Text] [PDF]

				P. Crosignani, D. Olive, A. Bergqvist, and A. Luciano Advances in the management of endometriosis: an update for clinicians Hum. Reprod. Update, March 1, 2006; 12(2): 179 - 189. [Abstract] [Full Text] [PDF]

				P.G. Crosignani, A. Luciano, A. Ray, and A. Bergqvist Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain Hum. Reprod., January 1, 2006; 21(1): 248 - 256. [Abstract] [Full Text] [PDF]

				K. Chwalisz, M. C. Perez, D. DeManno, C. Winkel, G. Schubert, and W. Elger Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis Endocr. Rev., May 1, 2005; 26(3): 423 - 438. [Abstract] [Full Text] [PDF]

				F. B. Lockhat, J. O. Emembolu, and J. C. Konje The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up Hum. Reprod., March 1, 2005; 20(3): 789 - 793. [Abstract] [Full Text] [PDF]

				M. K. Oehler, H. Greschik, D.-C. Fischer, X. Tong, R. Schuele, and D. G. Kieback Functional characterization of somatic point mutations of the human estrogen receptor {alpha} (hER{alpha}) in adenomyosis uteri Mol. Hum. Reprod., December 1, 2004; 10(12): 853 - 860. [Abstract] [Full Text] [PDF]